Design, synthesis, and antiproliferative and CDK2-cyclin A inhibitory activity of novel flavopiridol analogues

被引:37
作者
Ahn, Yu Mi
Vogeti, Lakshminarayana
Liu, Chun-Jing
Santhapuram, Hari K. R.
White, Jonathan M.
Vasandani, Veena
Mitscher, Lester A.
Lushington, Gerald H.
Hanson, Paul R.
Powell, Douglas R.
Himes, Richard H.
Roby, Katherine F.
Ye, Qizhuang
Georg, Gunda I.
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
[2] Univ Kansas, High Throughput Screening Lab, Lawrence, KS 66045 USA
[3] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA
[4] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA
[5] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA
关键词
flavopiridol analogues; synthesis; cytotoxicity; CDK2-cyclin A; docking simulations;
D O I
10.1016/j.bmc.2006.10.063
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The design and synthesis of a small library of 8-amidoflavone, 8-sulfonamidoflavone, 8-amido-7-hydroxyflavone, and heterocyclic analogues of flavopiridol is reported. The potential activity of these compounds as kinase inhibitors was evaluated by cytotoxicity studies in MCF-7 and ID-8 cancer cell lines and inhibition of CDK2-Cyclin A enzyme activity in vitro. The anti-proliferative and CDK2-Cyclin A inhibitory activity of these analogues was significantly lower than the activity of flavopiridol. Molecular docking simulations were carried out and these studies suggested a different binding orientation inside the CDK2 binding pocket for these analogues compared to flavopiridol. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:702 / 713
页数:12
相关论文
共 33 条
[1]   EPOXIDATION OF FLAVONES BY DIMETHYLDIOXIRANE [J].
ADAM, W ;
GOLSCH, D ;
HADJIARAPOGLOU, L ;
PATONAY, T .
JOURNAL OF ORGANIC CHEMISTRY, 1991, 56 (26) :7292-7297
[2]   Toward a pharmacophore for kinase frequent hitters [J].
Aronov, AM ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (23) :5616-5619
[3]   Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles [J].
Arris, CE ;
Boyle, FT ;
Calvert, AH ;
Curtin, NJ ;
Endicott, JA ;
Garman, EF ;
Gibson, AE ;
Golding, BT ;
Grant, S ;
Griffin, RJ ;
Jewsbury, P ;
Johnson, LN ;
Lawrie, AM ;
Newell, DR ;
Noble, MEM ;
Sausville, EA ;
Schultz, R ;
Yu, W .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (15) :2797-2804
[4]  
Carlson BA, 1996, CANCER RES, V56, P2973
[5]   Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors [J].
Chang, YT ;
Gray, NS ;
Rosania, GR ;
Sutherlin, DP ;
Kwon, S ;
Norman, TC ;
Sarohia, R ;
Leost, M ;
Meijer, L ;
Schultz, PG .
CHEMISTRY & BIOLOGY, 1999, 6 (06) :361-375
[6]   Issues and progress with protein kinase inhibitors for cancer treatment [J].
Dancey, J ;
Sausville, EA .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (04) :296-313
[7]   Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase [J].
deAzevedo, WF ;
MuellerDieckmann, HJ ;
SchulzeGahmen, U ;
Worland, PJ ;
Sausville, E ;
Kim, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (07) :2735-2740
[8]   Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics [J].
Fischer, PM ;
Lane, DP .
CURRENT MEDICINAL CHEMISTRY, 2000, 7 (12) :1213-1245
[9]   X-RAY CRYSTAL-STRUCTURE OF STAUROSPORINE - NEW ALKALOID FROM A STREPTOMYCES STRAIN [J].
FURUSAKI, A ;
HASHIBA, N ;
MATSUMOTO, T ;
HIRANO, A ;
IWAI, Y ;
OMURA, S .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1978, (18) :800-801
[10]   THE CRYSTAL AND MOLECULAR-STRUCTURE OF STAUROSPORINE, A NEW ALKALOID FROM A STREPTOMYCES STRAIN [J].
FURUSAKI, A ;
HASHIBA, N ;
MATSUMOTO, T ;
HIRANO, A ;
IWAI, Y ;
OMURA, S .
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, 1982, 55 (12) :3681-3685